Sector consensus Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 16:00:02 2024-09-13 EDT			5-day change	1st Jan Change
115.86 ^USD	+0.53%		-1.68%	+6.27%

09-12	Merck Says Health Canada Approved Keytruda as Treatment for Hard-to-Treat Solid Tumors	MT
09-11	Merck: positive results for HPV vaccine	CF

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
MERCK & CO., INC.	139.03	+19.99%	26
ELI LILLY AND COMPANY	995.42	+7.76%	25
NOVO NORDISK A/S	967.54	+5.34%	26
JOHNSON & JOHNSON	171.32	+3.51%	22
ABBVIE INC.	196.30	+1.08%	27
ROCHE HOLDING AG	297.08	+11.85%	19
ASTRAZENECA PLC	183.99	+17.35%	20
NOVARTIS AG	116.54	+0.65%	20
AMGEN INC.	324.71	-2.33%	24
PFIZER, INC.	33.23	+13.54%	22
SANOFI	112.17	+8.49%	22
GILEAD SCIENCES, INC.	83.54	+0.88%	27
BRISTOL-MYERS SQUIBB COMPANY	53.34	+8.57%	21
GSK PLC	19.68	+20.47%	21
CHUGAI PHARMACEUTICAL CO., LTD	6,663.33	-0.84%	15
DAIICHI SANKYO CO., LTD.	6,512.50	+26.83%	16
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4,768.83	+15.27%	18
HALEON PLC	3.865	-1.67%	17
JIANGSU HENGRUI MEDICINE CO., LTD.	58.20	+29.99%	15
Average	1,142.14	+9.83%	21
Weighted average by Cap.	711.97	+8.00%	23